Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CBS-catalyzed synthesis ensures high ee value and yield. Scalable process for antiviral intermediate supply chain stability and cost efficiency.
Novel synthesis route for aPKC inhibitor intermediates ensures high purity and scalable production for pharmaceutical supply chains.
Patent CN110423215B reveals a novel chalcone pyridinium salt synthesis enabling efficient nitrogen-bridged ring construction with mild conditions and high purity.
Patent CN102558004B reveals a novel synthesis route for S-(4-tolyl)benzenesulfonate using safer disulfides, offering significant cost reduction in pharma manufacturing.
Patent CN107325122B reveals a streamlined synthesis for prostaglandin intermediates, offering significant cost reduction and enhanced safety for pharmaceutical manufacturing.
Patent CN106117129B reveals a green oxidation route for pyridoxal using bismuth tungstate. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel preparation method of Bosutinib avoiding hazardous chlorinating agents. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN105693719A details iron-catalyzed synthesis of 3,3-spiro indolones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104557887B reveals a novel 1,8-naphthalimide synthesis with significant antitumor activity. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN107759510B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN108794396A details efficient oxidation of 4-oxo-2,3-dihydroquinolines. Offers high yield, low cost, and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN109651421A details a ruthenium-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN112142656B reveals a green biomass-copper catalyzed route for sulfonyl pyridine amides, offering cost-effective manufacturing and scalable pharmaceutical intermediate production.
Advanced synthesis of Belinostat intermediate II via safe esterification and HWE reactions. Reduces hazards and costs for HDAC inhibitor manufacturing.
Patent CN106188113B details water-soluble BODIPY synthesis. Offers improved purity and supply chain stability for pharmaceutical intermediate manufacturing processes.
Patent CN110563531A details a copper-catalyzed photocatalytic method for synthesizing 1,2-disubstituted olefins with high stereoselectivity and mild conditions for supply chain optimization.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN114249668B reveals safer PPTS catalysis for Zolpidem intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel patent CN109280055A enables scalable ergot alkaloid production. Reduced steps and enhanced chirality control for reliable pharmaceutical intermediate supply chains.
Patent CN102584509A reveals a green iodide-catalyzed amide synthesis. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.